Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN; 4 December 2006 - Protherics PLC ("Protherics" or the
"Company"), the international biopharmaceutical company focused on critical care
and cancer, announces that, on 1 December 2006, it received notification from
Barclays PLC that, as at 27 November 2006, Barclays PLC held an interest in
9,730,366 ordinary shares, representing 3.72% of the issued share capital of the
Company.
The issued share capital of the Company is 261,487,953 ordinary shares.
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, David Yates +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Interest in Shares
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- December 4, 2006 --